Neuropeptide FF receptor 2 overexpression aggravates lipid accumulation and metabolic dysfunction in mice with diet-induced metabolic stress
Authors:
Open Access
- 13 September 2025
- journal article
- Published by Elsevier in Biomedical Journal
- Vol. 49 (3) , 100913
Abstract
No abstract availableKeywords
Funding Information
- National Science and Technology Council
- Ministry of Science and Technology, Taiwan (110-2326-B-038-002-MY3)
- Ministry of Science and Technology, Taiwan (NSTC 113-2320-B-038-017)
This publication has 30 references indexed in Scilit:
- Modulatory role of neuropeptide FF system in macrophagesPeptides, 2024
- Hypothalamic NPFFR2 attenuates central insulin signaling and its knockout diminishes metabolic dysfunction in mouse models of diabetes mellitusClinical Nutrition, 2024
- Central NPFF signalling is critical in the regulation of glucose homeostasisMolecular Metabolism, 2022
- Expression analysis of neuropeptide FF receptors on neuroendocrine-related neurons in the rat brain using highly sensitive in situ hybridizationHistochemistry and Cell Biology, 2021
- Activation of NPFFR2 leads to hyperalgesia through the spinal inflammatory mediator CGRP in miceExperimental Neurology, 2017
- Altered nociception and morphine tolerance in neuropeptideFFreceptor type 2 over‐expressing miceEuropean journal of pain, 2015
- Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptorsNeuropharmacology, 2013
- Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight lossHepatology, 2004
- Obesity, diabetes and the central nervous systemDiabetologia, 1998
- The effects of two FMRFamide related peptides (A-18-F-amide and F-8-F-amide; ‘morphine modulating peptides’) on the endocrine and exocrine rat pancreasNeuropeptides, 1990